| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 11.02.
| Uptrend Call Working As Anika Therapeutics Stock Rises 68.4% | | - | SmarTrend |
| 11.02.
| Idexx Laboratories Shares Up 19.7% Since SmarTrend's Buy Recommendation | | - | SmarTrend |
| 10.02.
| Look for Shares of Hemispherx Biopharma to Potentially Pullback after Yesterday's 10.61% Rise | | - | SmarTrend |
| 10.02.
| Look for Shares of Medifast to Potentially Pullback after Yesterday's 2.00% Rise | | - | SmarTrend |
| 10.02.
| CytRx Rises 7.43% on Heavy Volume: Watch For Potential Pullback | | 2 | SmarTrend |
| 10.02.
| BIOVEST INTERNATIONAL INC - 10-Q, Quarterly Report | | - | SEC Filings |
| 10.02.
| Medivation Announces Participation at Upcoming Investor Conferences | | 29 | MarketWire |
| SAN FRANCISCO, CA -- (Marketwire) -- 02/10/12 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following investor conferences in February:
Patrick Machado, chief...
Mehr lesen zu:
Medivation Announces Participation at Upcoming Investor Conferences | |
| 10.02.
| Exelixis Announces February 14 Webcast of Presentation at 14th Annual BIO CEO & Investor Conference | | 44 | Business Wire |
| Exelixis, Inc. (NASDAQ:EXEL) today announced that Michael M. Morrissey,
Ph.D., the company's president and chief executive officer, will present
at the 14th annual BIO...
Mehr lesen zu:
Exelixis Announces February 14 Webcast of Presentation at 14th Annual BIO CEO & Investor Conference | |
| 10.02.
| Regeneron Announces February 13, 2012 as Date of Full Year 2011 Financial and Operating Results Conference Call and Webcast | | 40 | PR Newswire |
| TARRYTOWN, N.Y., Feb. 10, 2012 /PRNewswire/ --Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its fourth quarter and full year 2011 financial...
Mehr lesen zu:
Regeneron Announces February 13, 2012 as Date of Full Year 2011 Financial and Operating Results Conference Call and Webcast | |
| 10.02.
| Gen-Probe to Webcast Two Upcoming Investor Presentations | | 37 | PR Newswire |
| SAN DIEGO, Feb. 10, 2012 /PRNewswire/ --Gen-Probe Incorporated (NASDAQ: GPRO) announced today that the Company will present at the Leerink Swann 2012 Global Healthcare Conference...
Mehr lesen zu:
Gen-Probe to Webcast Two Upcoming Investor Presentations | |
| 10.02.
| Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BIO CEO and Investor Conference | | 44 | Business Wire |
| Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that its
presentation at the 14th Annual BIO CEO & Investor Conference will be
webcast and may be accessed at...
Mehr lesen zu:
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BIO CEO and Investor Conference | |
| 10.02.
| Amyris shares tumble on outlook | | 5 | Yahoo-USA |
| 10.02.
| InterMune Takes a Dive on Revenue Miss | | 1 | Schaeffer's Research |
| 10.02.
| Vernalis shares rise 28% after US cold medicine deal | | 2 | Guardian |
| 10.02.
| Fluidigm Moves up the Timing of Its Fourth Quarter/Full Year 2011 Financial Results Conference Call | | 46 | Business Wire |
| Fluidigm Corporation (NASDAQ:FLDM) will move the timing of its
conference call with investors to start at 1:30 p.m. PST (4:30 p.m. EST)
on February 14, 2012.
...
Mehr lesen zu:
Fluidigm Moves up the Timing of Its Fourth Quarter/Full Year 2011 Financial Results Conference Call | |
| 10.02.
| CytRx Up 6.0%, Penny Stock Attracts Attention | | 1 | SmarTrend |
| 10.02.
| Hot Stock: Corcept Therapeutics, Shares Drop 7.5% | | 1 | SmarTrend |
| 10.02.
| Enzo Biochem to Present at 2012 Leerink Swann Global Healthcare Conference | | 38 | Business Wire |
| Enzo
Biochem, Inc. (NYSE:ENZ), a vertically integrated biotechnology
company engaged in the research, development, manufacture, licensing and
marketing of innovative...
Mehr lesen zu:
Enzo Biochem to Present at 2012 Leerink Swann Global Healthcare Conference | |
| 10.02.
| Research and Markets: BML UK 2012 Travel Report - In The 52 Weeks Ending 4th September 2011, British Consumers Purchased an Estimated 7.3 Million Travel Guides and Spent 55m on Them | | 34 | Business Wire |
| Research and Markets(http://www.researchandmarkets.com/research/2ba7dc/bml_uk_2012_travel)
has announced the addition of the "BML
UK 2012 Travel Report" report to their...
Mehr lesen zu:
Research and Markets: BML UK 2012 Travel Report - In The 52 Weeks Ending 4th September 2011, British Consumers Purchased an Estimated 7.3 Million Travel Guides and Spent 55m on Them | |
| 10.02.
| Uptrend Call Working As Illumina Stock Rises 49.3% | | 4 | SmarTrend |
